Kelly is a PhD student in Cellular and Molecular Medicine to develop and validate treatments to stabilize the neuromuscular junction in a mouse model of ColQ congenital myasthenic syndrome (ColQ-CMS). She joined the Lochmüller team as a Master’s student in September 2021 to study the effects of forskolin and salbutamol in a ColQ-CMS mouse model, and transferred to the PhD program in April 2023.
She recently graduated with a BSc in Specialized Honours Kinesiology & Health Science at York University in 2021. During her undergraduate studies, she completed an Honours Thesis under the supervision of Dr. Dorota Anna Crawford, where she examined the motor coordination and dendritic morphology in the cerebellum of a mouse model for autism spectrum disorder.
Kelly looks forward to learning new techniques and gaining research experience as a part of the Lochmüller lab.